USNA

$14.87+1.02%visit website

USANA HEALTH SCIENCES INC

Market Cap

$275M

Live price × SEC shares (Aug 11, 2026)

Sector

Health Care

Industry

Medicinal Chemicals & Botanical Products

Beta (raw)

0.65

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jul 2026 · negative earnings

P/S (TTM)

0.3

TTM to Jul 2026 · revenue

P/B

0.5

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 27, 2025	Q4 FY2025 Jan 3, 2026	Q1 FY2026 Apr 4, 2026	Q2 FY2026 Jul 4, 2026	TTM Jul 4, 2026
Revenue	213,670	226,200	250,218	223,273	913,361
Cost of revenue	48,815	49,408	59,436	48,339	205,998
Gross profit	164,855	176,792	190,782	174,934	707,363
Selling, general & administrative	85,947	78,081	88,254	82,318	334,600
Total operating expenses	163,631	172,973	176,908	194,930	708,442
Operating income	1,224	3,819	13,874	(19,996)	(1,079)
Interest expense	49	123	240	0	412
Pretax income	1,794	4,177	15,465	(18,900)	2,536
Income tax	8,456	5,772	8,506	9,051	31,785
Net income	(6,522)	(1,775)	7,515	(21,382)	(22,164)
EPS (basic) ($)	(0.36)		0.41	(1.16)	(1.18)
EPS (diluted) ($)	(0.36)		0.41	(1.16)	(1.18)
Weighted avg. shares (basic)	18,293		18,398	18,486
Weighted avg. shares (diluted)	18,293		18,411	18,486

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jul 4, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jul 2010, with Tormere Pro.

Corporate Events (8-K)

9 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 4:10 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Oct 5, 2026 accepted 4:36 PM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Aug 4, 2026 accepted 4:22 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
May 20, 2026 accepted 4:24 PM ET	5.07Shareholder vote	Document SEC ↗
May 5, 2026 accepted 4:17 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Feb 18, 2026 accepted 8:33 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Feb 11, 2026 accepted 4:51 PM ET	8-K/A 5.02Officer / director change	Document SEC ↗
Jan 12, 2026 accepted 6:29 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jan 8, 2026 accepted 9:01 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Oct 22, 2025 accepted 4:12 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

27%

W/W -20.3pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-16	2026-06-18	Neidig Brent	CHIEF COMMERCIAL OFFICER	Sale	5,002	$19.45	$97K	0	View
2026-06-15	2026-06-16	Neidig Brent	CHIEF COMMERCIAL OFFICER	Sale	909	$20.00	$18K	5,002	View
2026-06-12	2026-06-16	Neidig Brent	CHIEF COMMERCIAL OFFICER	Sale	1,602	$20.15	$32K	5,911	View
2026-06-01	2026-06-01	Fleming John Turman	Director	Sale	2,450	$17.93	$44K	4,230	View
2026-05-28	2026-05-29	Jones Paul A.	CHIEF PEOPLE OFFICER	Sale	6,813	$18.95	$129K	5,561	View